14 results
8-K
EX-2.1
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
the Closing.
(b) Seller is not a party to any labor or collective bargaining Contract that pertains to any Specified Business Employees … . There are no, and during the past five years have been no, organizing activities or collective bargaining arrangements that could affect the Specified Business pending
10-K
2019 FY
MIRM
Mirum Pharmaceuticals Inc
12 Mar 20
Annual report
4:16pm
. degrees. None of our employees is subject to a collective bargaining agreement. We consider our relationship with our employees to be good.
Corporate
424B4
2die41q7gdx3pi tggj
9 Jan 20
Prospectus supplement with pricing info
5:11pm
DRS
5xd 7dkyn3f4r7zq
27 Dec 19
Draft registration statement
12:00am
424B4
kqp72vp6aunayr effh
18 Jul 19
Prospectus supplement with pricing info
4:04pm
S-1
glryk06s49hy srcej
21 Jun 19
IPO registration
3:24pm
DRS/A
jhwi9pxgpi7v1zi2qw0
24 May 19
Draft registration statement (amended)
12:00am
DRS
b664m3ka
18 Apr 19
Draft registration statement
12:00am
- Prev
- 1
- Next